200 related articles for article (PubMed ID: 31749810)
1. Mass Cytometry Reveals a Sustained Reduction in CD16
Shinko D; McGuire HM; Diakos CI; Pavlakis N; Clarke SJ; Byrne SN; Charles KA
Front Immunol; 2019; 10():2584. PubMed ID: 31749810
[TBL] [Abstract][Full Text] [Related]
2. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.
Cui F; Qu D; Sun R; Nan K
Med Oncol; 2019 Sep; 36(10):84. PubMed ID: 31493232
[TBL] [Abstract][Full Text] [Related]
3. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2019 Feb; 197(1):53-60. PubMed ID: 30523401
[TBL] [Abstract][Full Text] [Related]
6. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
Gomez-Muñoz L; Perna-Barrull D; Villalba A; Rodriguez-Fernandez S; Ampudia RM; Teniente-Serra A; Vazquez F; Murillo M; Perez J; Corripio R; Bel J; Vives-Pi M
Front Immunol; 2020; 11():611522. PubMed ID: 33569058
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.
Zhou C; Wang Z; Jiang B; Di J; Su X
Front Immunol; 2022; 13():807539. PubMed ID: 35185893
[TBL] [Abstract][Full Text] [Related]
9. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
10. NK cells and the profile of inflammatory cytokines in the peripheral blood of patients with advanced carcinomas.
Saito LM; Ortiz RC; Amôr NG; Lopes NM; Buzo RF; Garlet GP; Rodini CO
Cytokine; 2024 Feb; 174():156455. PubMed ID: 38043142
[TBL] [Abstract][Full Text] [Related]
11. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
12. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
13. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.
Dowell AC; Oldham KA; Bhatt RI; Lee SP; Searle PF
Cancer Immunol Immunother; 2012 May; 61(5):615-28. PubMed ID: 22021067
[TBL] [Abstract][Full Text] [Related]
14. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
15. A New Hope for CD56
Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
[TBL] [Abstract][Full Text] [Related]
16. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
17. A population of atypical CD56(-)CD16(+) natural killer cells is expanded in PTSD and is associated with symptom severity.
Bersani FS; Wolkowitz OM; Milush JM; Sinclair E; Eppling L; Aschbacher K; Lindqvist D; Yehuda R; Flory J; Bierer LM; Matokine I; Abu-Amara D; Reus VI; Coy M; Hough CM; Marmar CR; Mellon SH
Brain Behav Immun; 2016 Aug; 56():264-70. PubMed ID: 27025668
[TBL] [Abstract][Full Text] [Related]
18. Increased ILT2 expression contributes to dysfunction of CD56
Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
20. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
